Anum Glasgow is an assistant professor in the Department of Biochemistry and Molecular Biophysics at Columbia University. She received a PhD from UC Berkeley, where she engineered a bacterial protein secretion system for applications in biotech in Dr. Danielle Tullman-Ercek’s group. Anum pivoted from her experimental background to work in computational biophysics to build biological sensors and antiviral therapeutics as a postdoctoral fellow in Dr. Tanja Kortemme’s group at UC San Francisco. Her postdoctoral work includes the first example of a de novo-designed chemically inducible dimerization system, in which two proteins bind a small molecule to generate programmable cellular responses. During the COVID-19 pandemic, Anum co-led a team to rapidly develop a receptor trap therapeutic for treating SARS-CoV-2 infections. Anum continues to build and apply experimental and computational approaches to probe how protein systems evolve, undergo conformational changes, and interact with other biomolecules, while maintaining a focus on biotherapeutics development.